EFFICACY AND SAFETY OF COMPOUND-RESERPINE-TRIAMTERENE TABLETSIN TREATMENT TO NON-DIPPER HYPERTENSION IN ELDERLY

被引：0

作者：

Wang, Hongyi ^{[1
]}

Chen, Yuanyuan ^{[1
]}

Ma, Zhiyi ^{[1
]}

Yang, Fan ^{[1
]}

Sun, Ningling ^{[1
]}

Wang, Hongyi ^{[1
]}

机构：

[1] Peking Univ, Peoples Hosp, Heart Ctr, Beijing, Peoples R China

来源：

JOURNAL OF HYPERTENSION | 2018年 / 36卷

关键词：

compound-reserpine-triamterene tablets; elderly hypertension; blood pressure rhythm; chronotherapeutics;

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

A13979

引用

页码：E225 / E225

页数：1

共 48 条

[41] Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas
Fabbri, Alberto
Cencini, Emanuele
Rigacci, Luigi
Bartalucci, Giulia
Puccini, Benedetta
Dottori, Roberto
Gozzetti, Alessandro
Bosi, Alberto
Bocchia, Monica
LEUKEMIA & LYMPHOMA, 2014, 55 (04) : 781 - 785
[42] Safety and efficacy of paclitaxel liposome monotherapy for the treatment of elderly patients with advanced non-small cell lung cancer: A prospective, multicenter, uncontrolled phase II study
Ding, Zhenyu
Zhou, Lin
Lu, You
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[43] A Meta-analysis of the Clinical Efficacy and Safety of Radiofrequency Ablation (RFA) in the Treatment of Elderly Patients with Stage III-IV Non-small Cell Lung Cancer
Li, R.
Wu, H.
Yang, F.
Cai, Q. Q.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S16 - S17
[44] Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations
Hisao Imai
Hiroyuki Minemura
Tomohide Sugiyama
Yutaka Yamada
Kyoichi Kaira
Kenya Kanazawa
Takashi Kasai
Takayuki Kaburagi
Koichi Minato
Cancer Chemotherapy and Pharmacology, 2018, 82 : 119 - 127
[45] Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations
Imai, Hisao
Minemura, Hiroyuki
Sugiyama, Tomohide
Yamada, Yutaka
Kaira, Kyoichi
Kanazawa, Kenya
Kasai, Takashi
Kaburagi, Takayuki
Minato, Koichi
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (01) : 119 - 127
[46] Efficacy and safety of low-dose albumin-bound paclitaxel plus tislelizumab as second- or further lines treatment for elderly patients with metastatic non-small cell lung cancer.
Geng, Qian
Li, Dongqing
Zhu, Wenyu
Peng, Haoliang
Jin, Zhihui
Jiang, Hua
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[47] A multicenter randomized controlled open-label trial to assess the efficacy of compound kushen injection in combination with single-agent chemotherapy in treatment of elderly patients with advanced non-small cell lung cancer: study protocol for a randomized controlled trial
Wang, Xue-qian
Liu, Jie
Lin, Hong-sheng
Hou, Wei
TRIALS, 2016, 17
[48] A multicenter randomized controlled open-label trial to assess the efficacy of compound kushen injection in combination with single-agent chemotherapy in treatment of elderly patients with advanced non-small cell lung cancer: study protocol for a randomized controlled trial
Xue-qian Wang
Jie Liu
Hong-sheng Lin
Wei Hou
Trials, 17

← 1 2 3 4 5 →